{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T08:03:22Z","timestamp":1790669002977,"version":"4.1.0"},"reference-count":33,"publisher":"Impact Journals, LLC","issue":"17","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,4,25]]},"DOI":"10.18632\/oncotarget.15957","type":"journal-article","created":{"date-parts":[[2017,3,9]],"date-time":"2017-03-09T14:34:49Z","timestamp":1489070089000},"page":"28906-28921","source":"Crossref","is-referenced-by-count":32,"title":["Stellettin B induces apoptosis in human chronic myeloid leukemia cells via targeting PI3K and Stat5"],"prefix":"10.18632","volume":"8","author":[{"given":"Yali","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Biopharmaceutical Sciences, Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics, School of Pharmacy, Tianjin Medical University, Tianjin 300070, China"},{"name":"Research Center of Basic Medical Sciences, Tianjin Medical University, Tianjin 300070, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianxiang","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Biopharmaceutical Sciences, Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics, School of Pharmacy, Tianjin Medical University, Tianjin 300070, China"},{"name":"Research Center of Basic Medical Sciences, Tianjin Medical University, Tianjin 300070, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Biopharmaceutical Sciences, Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics, School of Pharmacy, Tianjin Medical University, Tianjin 300070, China"},{"name":"Research Center of Basic Medical Sciences, Tianjin Medical University, Tianjin 300070, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxu","family":"Zhong","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanwei","family":"Fan","sequence":"additional","affiliation":[{"name":"Institute of Traditional Chinese Medicine Research, State Key Laboratory of Modern Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Biopharmaceutical Sciences, Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics, School of Pharmacy, Tianjin Medical University, Tianjin 300070, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Biopharmaceutical Sciences, Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics, School of Pharmacy, Tianjin Medical University, Tianjin 300070, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meihua","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Biopharmaceutical Sciences, Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics, School of Pharmacy, Tianjin Medical University, Tianjin 300070, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuling","family":"Qiu","sequence":"additional","affiliation":[{"name":"Department of Biopharmaceutical Sciences, Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics, School of Pharmacy, Tianjin Medical University, Tianjin 300070, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dexin","family":"Kong","sequence":"additional","affiliation":[{"name":"Department of Biopharmaceutical Sciences, Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics, School of Pharmacy, Tianjin Medical University, Tianjin 300070, China"},{"name":"Research Center of Basic Medical Sciences, Tianjin Medical University, Tianjin 300070, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,3,7]]},"reference":[{"issue":"24","key":"1","first-page":"115","article-title":"Cathepsin B release after imatinib-mediated lysosomal membrane permeabilization triggers BCR-ABL cleavage and elimination of chronic myelogenous leukemia cells","volume":"2010","author":"Auberger","journal-title":"Leukemia"},{"issue":"28","key":"2","first-page":"2165","article-title":"Low expression of Abelson interactor-1 is linked to acquired drug resistance in Bcr-Abl-induced leukemia","volume":"2014","author":"Winer","journal-title":"Leukemia"},{"issue":"5","key":"3","doi-asserted-by":"publisher","first-page":"8637","DOI":"10.18632\/oncotarget.2353","article-title":"Selective JAK2\/ABL dual inhibition therapy effectively eliminates TKI-insensitive CML stem\/progenitor cells","volume":"2014","author":"Jiang","journal-title":"Oncotarget"},{"issue":"36","key":"4","first-page":"32","article-title":"Strategies for the Optimization of Natural Leads to Anticancer Drugs or Drug Candidates","volume":"2016","author":"Lee","journal-title":"Med Res Rev"},{"issue":"12","key":"5","first-page":"636","article-title":"Marine low molecular weight natural products as potential cancer preventive compounds","volume":"2014","author":"Fedorov","journal-title":"Mar Drugs"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Jin, Quan, Hou, Fan. Potential Pharmacological Resources: Natural Bioactive Compounds from Marine-Derived Fungi. Mar Drugs. 2016(14):76.","DOI":"10.3390\/md14040076"},{"issue":"28","key":"7","first-page":"196","article-title":"Marine natural products","volume":"2011","author":"Prinsep","journal-title":"Nat Prod Rep"},{"issue":"6","key":"8","first-page":"480","article-title":"Smenospongine, a sesquiterpene aminoquinone from a marine sponge, induces G1 arrest or apoptosis in different leukemia cells","volume":"2008","author":"Kobayashi","journal-title":"Mar Drugs"},{"issue":"12","key":"9","first-page":"7352","article-title":"Antiproliferative effect of aaptamine on human chronic myeloid leukemia K562 cells","volume":"2011","author":"Kong","journal-title":"Int J Mol Sci"},{"issue":"12","key":"10","first-page":"4200","article-title":"antitumor activity of stellettin B, a triterpene from marine sponge Jaspis stellifera, on human glioblastoma cancer SF295 cells","volume":"2014","author":"Kong","journal-title":"Mar Drugs"},{"issue":"6","key":"11","first-page":"27071","article-title":"Induces G1 Arrest, Apoptosis and Autophagy in Human Non-small Cell Lung Cancer A549 Cells via Blocking PI3K\/Akt\/mTOR Pathway","volume":"2016","author":"Stellettin","journal-title":"Sci Rep"},{"issue":"20","key":"12","first-page":"e52727","article-title":"Utilization of the Soft Agar Colony Formation Assay to Identify Inhibitors of Tumorigenicity in Breast Cancer Cells","volume":"2015","author":"Coonrod","journal-title":"J Vis Exp"},{"issue":"87","key":"13","first-page":"1157","article-title":"Oxidative stress: the mitochondria-dependent and mitochondria-independent pathways of apoptosis","volume":"2013","author":"Sil","journal-title":"Arch Toxicol"},{"issue":"86","key":"14","first-page":"1272","article-title":"Ridaifen-SB8, a novel tamoxifen derivative, induces apoptosis via reactive oxygen species-dependent signaling pathway","volume":"2013","author":"Dan","journal-title":"Biochem pharmacol"},{"issue":"34","key":"15","first-page":"1363","article-title":"Stat5 regulates the phosphatidylinositol 3-kinase\/Akt1 pathway during mammary gland development and tumorigenesis","volume":"2014","author":"Wagner","journal-title":"Mol Cell Biol"},{"issue":"14","key":"16","first-page":"151","article-title":"Pharmacological inhibition of poly(ADP-ribose) polymerase-1 modulates resistance of human glioblastoma stem cells to temozolomide","volume":"2014","author":"Graziani","journal-title":"BMC cancer"},{"issue":"7","key":"17","doi-asserted-by":"publisher","first-page":"5193","DOI":"10.18632\/oncotarget.6405","article-title":"Bcl-2 family proteins as regulators of cancer cell invasion and metastasis: a review focusing on mitochondrial respiration and reactive oxygen species","volume":"2016","author":"Um","journal-title":"Oncotarget"},{"issue":"7","key":"18","first-page":"a006080","article-title":"Cell Death Signaling","volume":"2015","author":"Llambi","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"131","key":"19","first-page":"592","article-title":"Typhonium flagelliforme induces apoptosis in CEMss cells via activation of caspase-9, PARP cleavage and cytochrome c release: its activation coupled with G0\/G1 phase cell cycle arrest","volume":"2010","author":"Syam","journal-title":"J Ethnopharmacol"},{"issue":"58","key":"20","first-page":"131","article-title":"Targeting a mitochondrial potassium channel to fight cancer","volume":"2015","author":"Becker","journal-title":"Cell Calcium"},{"issue":"1655","key":"21","first-page":"400","article-title":"The possible role of cytochrome c oxidase in stress-induced apoptosis and degenerative diseases","volume":"2004","author":"Huttemann","journal-title":"Biochim Biophys Acta"},{"issue":"8","key":"22","first-page":"945","article-title":"Activated STAT Signaling in Human Tumors Provides Novel Molecular Targets for Therapeutic Intervention","volume":"2002","author":"Jove","journal-title":"Clin Cancer Res"},{"issue":"109","key":"23","first-page":"1139","article-title":"Stat proteins and oncogenesis","volume":"2002","author":"Bromberg","journal-title":"J Clin Invest"},{"issue":"95","key":"24","first-page":"2118","article-title":"STAT5 activation contributes to growth and viability in Bcr\/Abl-transformed cells","volume":"2000","author":"Griffin","journal-title":"Blood"},{"issue":"12","key":"25","first-page":"513","article-title":"Pushing the limits of targeted therapy in chronic myeloid leukaemia","volume":"2012","author":"Deininger","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"26","first-page":"5694","article-title":"Increased MAPK reactivation in early resistance to dabrafenib\/trametinib combination therapy of BRAF-mutant metastatic melanoma","volume":"2014","author":"Johansson","journal-title":"Nat Commun"},{"issue":"124","key":"27","first-page":"8","article-title":"IVSE, isolated from Inula japonica, suppresses LPS-induced NO production via NF-kappaB and MAPK inactivation in RAW264.7 cells","volume":"2015","author":"Kong","journal-title":"Life Sci"},{"issue":"45","key":"28","first-page":"857","article-title":"Antiangiogenic effect of ZSTK474, a novel phosphatidylinositol 3-kinase inhibitor","volume":"2009","author":"Yamori","journal-title":"Eur J Cancer"},{"issue":"14","key":"29","first-page":"2773","article-title":"MEK Inhibitor Selumetinib (AZD6244; ARRY-142886) Prevents Lung Metastasis in a Triple-Negative Breast Cancer Xenograft Model","volume":"2015","author":"Ueno","journal-title":"Mol Cancer Ther"},{"issue":"12","key":"30","first-page":"631","article-title":"Antileukemia Activity of ZSTK474 on K562 and Multidrug Resistant K562\/A02 Cells","volume":"2016","author":"Kong","journal-title":"Int J Biol Sci"},{"issue":"7","key":"31","doi-asserted-by":"publisher","first-page":"19897","DOI":"10.18632\/oncotarget.7658","article-title":"ZSTK474, a specific class I phosphatidylinositol 3-kinase inhibitor, induces G1 arrest and autophagy in human breast cancer MCF-7 cells","volume":"2016","author":"Kong","journal-title":"Oncotarget"},{"issue":"14","key":"32","first-page":"13577","article-title":"antimetastatic effect of phosphatidylinositol 3-kinase inhibitor ZSTK474 on prostate cancer PC3 cells","volume":"2013","author":"Kong","journal-title":"Int J Mol Sci"},{"issue":"32","key":"33","first-page":"1134","article-title":"multifaceted activities of a specific group of novel phosphatidylinositol 3-kinase inhibitors on hotspot mutant PIK3CA","volume":"2014","author":"Dan","journal-title":"Invest New Drugs"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.15957","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,10]],"date-time":"2020-05-10T14:46:35Z","timestamp":1589121995000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.15957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,7]]},"references-count":33,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2017,4,25]]}},"alternative-id":["15957","28423649"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.15957","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,7]]}}}